AC Immune SA Cash Flow Statement

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024 Sep2025
Operating Activities
Net Income 0.01B0.02B-0.01B-0.03B-0.05B0.05B-0.07B-0.08B-0.07B-0.06B-0.06B
Depreciation and Depletion 0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Share-based Compensation 0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.01B
Gains from Investment Securities -0.00B0.00B-0.00B
Non-cash Items 0.00B0.00B0.00B131.64B54.52B71.70B1,566.26B2,437.18B
Cash from Operations -0.02B0.04B-0.01B-0.02B-0.04B0.06B-0.07B-0.07B-0.08B-0.07B0.07B
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) 0.00B0.00B-0.00B-0.00B-0.00B-0.00B-0.01B-0.01B0.00B0.00B0.00B
Change in Working Capital
Change in Receivables 0.03B-0.00B-0.00B0.00B-0.00B-0.00B-0.00B0.00B-0.02B0.02B
Change in Account Payables -0.00B0.00B-0.00B0.00B-0.00B0.00B-0.00B-0.00B0.00B0.00B
Change in Accured Expenses 0.00B-0.00B0.01B
Other Working Capital Changes -0.00B0.00B0.00B0.00B0.00B-0.00B0.00B-0.00B-0.00B0.00B
Investing Activities
Capital Expenditures -0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Sales of Property, Plant and Equipment 0.00B
Cash from Investing Activities -0.00B-0.00B-0.00B-0.00B-0.03B-0.07B0.03B-0.06B0.02B0.07B-0.12B
Financing Activities
Cash from Financing Activities 0.01B0.03B0.08B0.00B0.11B0.05B-0.00B0.04B-0.00B0.05B-0.00B
Change in Capital Stock
Net Equity Issued and Repurchased 0.00B0.00B0.00B0.05B0.03B
Additional items
Exchange Rate Effect 0.00B0.00B0.00B-0.00B-0.00B-0.00B-0.00B-0.00B0.00B-0.00B-0.00B
Change in Cash -0.01B0.07B0.07B-0.02B0.03B0.04B-0.04B-0.09B-0.05B0.05B-0.05B
Beginning Cash Balance 0.01B0.00B0.08B0.15B0.12B0.16B0.21B0.18B0.09B0.03B0.09B0.03B
Free Cash Flow -0.02B0.04B-0.01B-0.02B-0.05B0.05B-0.07B-0.07B-0.08B-0.07B0.07B
Net Cash Flow -0.01B0.07B0.07B-0.02B0.03B0.04B-0.04B-0.09B-0.05B0.05B-0.05B